GLP1R and pancreatitis: Given that GLP-1 and GLP-2 are structurally related by a common precursor protein [23], proglucagon, it is possible that the increased pancreatitis risk associated with GLP-1 and GLP-2 agonists may be mediated by similar biological mechanisms.